Real-world use and predictors of response to disopyramide in patients with obstructive hypertrophic cardiomyopathy

HIGHLIGHTS

• who: Niccolu00f2 Maurizi and colleagues from the Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy have published the research: Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy, in the Journal: (JOURNAL)
• what: This study shows that disopyramide was underused since the 1980s in a historical and large cohort of patients with obstructive HCM, being offered to up to one-third
• future: Lastly further prospective studies would be needed to compare negative inotropic drugs with myosin 9 of 10 inhibitors specifically in the subset . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.